← Back to Search
Piroxicam Solid State Studies After Processing With SAS Technique
N. D. Zordi, I. Kikic, M. Moneghini, D. Solinas
Published 2010 · Chemistry
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Supercritical carbon dioxide (SCO 2 ) was used as anti-solvent to precipitate Piroxicam, a nonsteroidal anti-inflammatory drug, from different organic solvents (acetone, ethyl acetate and dichloromethane). Physicochemical properties of the samples were analyzed before and after the treatment to highlight possible changes in the form of the crystals. The solid state analysis of both products untreated and treated with CO 2 , showed that the applied method choose a particle size reduction and transition to the pure α form resulting in needle-shaped crystals, regardless of the chosen solvent. In order to identify which process was responsible for the above results, Piroxicam was further precipitated from the same three solvents by traditional evaporation method (RV-samples). The dissolution profiles of Piroxicam processed in SCO 2 show a better dissolution performance of Piroxicam over their corresponding system obtained by traditional evaporation method. These results manifest that SAS technology is a controllable way to improve bioavailability of water-insoluble drugs.
This paper references
Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method.
S. Sethia (2002)
Supercritical Fluids Crystallization of Budesonide and Flunisolide
S. Velaga (2004)
Precipitation Processes with Supercritical Fluids: Patents Review
M. J. Mart'in (2008)
Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized From Supercritical Fluids
H. Tong (2004)
Polymorphism in Pharmaceutical Solids
H. Brittain (1999)
Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes.
A. Sheth (2005)
Control of the Physical Form of Salmeterol Xinafoate
Steve Beach (1999)
Properties of Gases and Liquids
R. Reid (1977)
Ways of manipulating the polymorphism of glycine during supercritical fluid crystallisation
A. Bouchard (2008)
Recrystallization of sulfathiazole and chlorpropamide using the supercritical fluid antisolvent process
Sang-Do Yeo (2003)
DELOS process: a crystallization technique using compressed fluids: 1. Comparison to the GAS crystallization method
N. Ventosa (2003)
Solubility and Micronization of Griseofulvin in Supercritical Chf3
E. Reverchon (1995)
Crystallization of sulfamethizole using the supercritical and liquid antisolvent processes
Sang-Do Yeo (2004)
Polymorphism in Piroxicam
A. Sheth (2004)
Particle generation for pharmaceutical applications using supercritical fluid technology
J. Fages (2004)
THEORY AND ORIGIN OF POLYMORPHISM
D. J. Grant (1999)
Characterization of piroxicam crystal modifications.
F. Vrečer (2003)
Investigation of piroxicam polymorphism
F. Vrecˇer (1991)
Generation of microparticles using CO2 and CO2‐philic antisolvents
M. Sarkari (2000)
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
G. Amidon (2004)
Volume expansions and vapor-liquid equilibria of binary mixtures of a variety of polar solvents and certain near-critical solvents
A. Kordikowski (1995)
Polymorph Control of Sulfathiazole in Supercritical CO2
A. Kordikowski (2004)
Anti-solvent and co-solvent effect of CO2 on the solubility of griseofulvin in acetone and ethanol solutions
B. D. Gioannis (2004)
Study of the solid state of carbamazepine after processing with gas anti-solvent technique.
M. Moneghini (2003)
Isothermal Vapor-Liquid Equilibrium Data for Binary Systems Containing Carbon Dioxide at High Pressures: Methanol-Carbon Dioxide, n-Hexane-Carbon Dioxide, and Benzene-Carbon Dioxide Systems
K. Ohgaki (1976)
Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution.
M. Moneghini (2001)
Production of Polymorphs of Ibuprofen Sodium by Supercritical Antisolvent (SAS) Precipitation
Ángel Martín (2009)
Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
M. Moneghini (2010)
Solvent effect on tolbutamide crystallization induced by compressed CO2 as antisolvent
P. Subra-Paternault (2007)
A comparison between semi-empirical and molecular-based equations of state for describing the thermodynamic of supercritical micronization processes
Sara Colussi (2006)
Solubility of Anti-Inflammatory Drugs in Supercritical Carbon Dioxide
S. J. Macnaughton (1996)
Encapsulation and co-precipitation processes with supercritical fluids: Fundamentals and applications
M. J. Cocero (2009)
CHARACTERIZATION OF POWDER PARTICLE MORPHOLOGY
V. Mikli (2001)
This paper is referenced by
Antisolvent Precipitation of Vitamin B6: A Thermodynamic Study
I. Kikic (2011)
Formation of Cyclodextrin-Drug Inclusion Compounds and Polymeric Drug Delivery Systems using Supercritical Carbon Dioxide
Heather E. Grandelli (2013)
Survey of supercritical fluid techniques for producing drug delivery systems for a potential use in cancer therapy
A. Tabernero (2016)
Melting point depression of Piroxicam in carbon dioxide + co-solvent mixtures and inclusion complex formation with β-cyclodextrin
Heather E. Grandelli (2012)
Solubility of pharmaceutical compounds in supercritical carbon dioxide
N. D. Zordi (2012)
Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
J. Zhang (2013)
Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
Nicola De Zordi (2012)
Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
S. M. Abuzar (2018)
Critical gases for critical issues: CO2 technologies for oral drug delivery.
H. Danan (2014)
Solid state transformations in consequence of electrospraying--a novel polymorphic form of piroxicam.
M. Nyström (2015)
Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Cheng Zhang (2012)
olubility of pharmaceutical compounds in supercritical carbon dioxide
De Zordia (2011)
Excess molar enthalpies for mixtures of supercritical CO2 and ethyl acetate and their role in supercritical fluid applications
F. Zahran (2012)
Engineering Active Pharmaceutical Ingredients by Spray Drying: Effects on Physical Properties and In Vitro Dissolution
R. Martins (2012)